3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Head & Neck
2
Other
1
Lymphoid
1
Conditions
Lymphoma
128
Leukemia, Lymphocytic, Chronic, B-Cell
96
Precursor Cell Lymphoblastic Leukemia-Lymphoma
90
Lymphoma, Non-Hodgkin
83
Lymphoma, Follicular
76
Lymphoma, Large B-Cell, Diffuse
71
Leukemia
60
Lymphoma, Mantle-Cell
51
Burkitt Lymphoma
48
Hodgkin Disease
44
Leukemia, Myeloid, Acute
42
Lymphoma, B-Cell, Marginal Zone
41
Lymphoma, B-Cell
40
Recurrence
38
Lymphoma, T-Cell, Cutaneous
27
Mycosis Fungoides
26
Myelodysplastic Syndromes
25
Waldenstrom Macroglobulinemia
24
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
24
Multiple Myeloma
21
Lymphoma, Large-Cell, Immunoblastic
21
Lymphoma, Large-Cell, Anaplastic
21
Sezary Syndrome
19
Neoplasms
19
Hematologic Neoplasms
18
Myeloproliferative Disorders
17
Lymphoma, Extranodal NK-T-Cell
16
Leukemia, Myelomonocytic, Chronic
14
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
14
Leukemia, Biphenotypic, Acute
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Gastroesophageal Reflux
×
Lymphoid
×
Clear all
NCT02722551
2018-01-09
RELIEF
Edwards Lifesciences
Phase 1/2
Withdrawn